Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma.

Four of 12 Chinese patients receiving BACOP, in combination with recombinant human granulocyte colony-stimulating factor, for aggressive non-Hodgkin's lymphoma developed a rapidly progressive pneumonic illness characterised by diffuse pulmonary infiltrates and hypoxaemia. The condition proved f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, K. I., Leung, W. T., Johnson, P. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033539/
https://www.ncbi.nlm.nih.gov/pubmed/7524599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033539/
https://www.ncbi.nlm.nih.gov/pubmed/7524599

Ejemplares similares